patients look distinguishing characteristics patients certain genes paves way precision medicine approach meaning patients tested drug determine likely effective exciting drug come berg work exciting emerge drug discovery related ai effort date cancer drug called bpm31510 recently completed phase 2 trial patients advanced pancreatic cancer extremely aggressive difficult treat phase 1 trials not indicate drug potential dangerously toxic given dose bpm31510 phase 1 trial cancers provided verification ability berg software predict roughly 20 percent patients likely respond likely experience adverse reactions additionally tissue sample analysis trial led berg software predict counterintuitively drug work best aggressive cancers attacks mechanisms play larger